Agoracom Blog Home

Posts Tagged ‘small cap’

Else Nutrition $BABY.ca $BABYF Upgraded to OTCQX Best Market $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 8:56 AM on Friday, July 24th, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png
  • Announced that its common shares have been approved for trading on the OTCQX® Best Market, a U.S. market operated by the OTC Markets Group
  • Else Nutrition’s shares were previously traded on the OTCQB® Venture Market
  • “We are very excited to have qualified to upgrade our US trading to the OTCQX Market,” commented Ms. Hamutal Yitzhak, Else Nutrition CEO and Co-Founder

VANCOUVER, BC, July 24, 2020 – Else Nutrition Holdings Inc. (TSXV: BABY) (OTCQX: BABYF) (FSE: 0YL) (“Else” or the “Company”), is pleased to announce that its common shares have been approved for trading on the OTCQX® Best Market, a U.S. market operated by the OTC Markets Group. Else Nutrition’s shares were previously traded on the OTCQB® Venture Market.

“We are very excited to have qualified to upgrade our US trading to the OTCQX Market,” commented Ms. Hamutal Yitzhak, Else Nutrition CEO and Co-Founder. “We believe that trading on the OTCQX Market will further raise visibility of Else Nutrition in the US and international marketplace as well as enhance trading liquidity and expand our shareholder base.”

The OTCQX Market is designed for established, investor-focused companies. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance, and demonstrate compliance with applicable securities laws. Graduating to the OTCQX Market from the OTCQB Market marks an important milestone for companies, enabling them to demonstrate their qualifications and build visibility among U.S. and international investors.

The Company also announces that its board of directors has approved on the issuance of incentive stock options (collectively, the “Options”) to a number of its directors, officers, employees and consultants to purchase up to a total of 1,462,250 common shares in the capital of the Company (each, a “Common Share”). Of such Options, an aggregate of 687,500 Options are allocated to the directors and officers. This is a normal-course option grant that comprises part of the long-term compensation and retention incentives provided by the Company.

Each Option is exercisable into one Common Share up to five years from the issuing date at a price of CND $2.19 per Common Share or in the case of 72,000 Options to be granted to a certain consultant, at the closing price of the Common Shares on TSX Venture Exchange on the date immediately preceding the effective Option grant. The grant of the Options is subject to approval from the TSX Venture Exchange and the terms and conditions of the Company’s shareholder approved 2019 Stock Option Plan.Else Nutrition shares also trade on the TSX Venture Exchange under the symbol BABY and on the Frankfurt Stock Exchange under the symbol 0YL.

About OTC Markets Group Inc.

OTC Markets Group Inc. (OTCQX: OTCM) operates the OTCQX® Best Market, the OTCQB® Venture Market and the Pink® Open Market for 10,000 U.S. and global securities. Through OTC Link® ATS and OTC Link ECN, we connect a diverse network of broker-dealers that provide liquidity and execution services. We enable investors to easily trade through the broker of their choice and empower companies to improve the quality of information available for investors.

To learn more about how we create better informed and more efficient markets, visit www.otcmarkets.com.

OTC Link ATS and OTC Link ECN are SEC regulated ATSs, operated by OTC Link LLC, member FINRA/SIPC.

About Else Nutrition Holdings Inc.

Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan. The holding company, Else Nutrition Holdings Inc, is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QB board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board  members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies,  and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children’s Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium

For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among othersForward-looking statements made in this press release assume, among others, the timing of the Company’s toddler nutrition product launch and the availability of the Company’s product online. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements.  Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

TransCanna $TCAN.ca Seizes New Processing Opportunity and Expands Operations at Daly Street Building $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 4:15 PM on Wednesday, July 22nd, 2020
tcan-square
  • Announced that Lyfted Farms Inc. (a wholly-owned subsidiary) will build a processing division inside its Daly Street Building
  • Aas not originally planned in phase one in order to meet the increased demand for this service and ultimately increase profits margins
  • Once operational, the division will oversee the trimming, drying, curing, grading and packaging of cannabis, and support TransCanna’s strategy of vertical integration of the California cannabis market through distribution centers serving Northern California from the Daly Street building, and Southern California from the Company’s recently announced Lemoore facility

Vancouver, British Columbia–(July 22, 2020) – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) TransCanna announces that Lyfted Farms Inc. (a wholly-owned subsidiary) will build a processing division inside its Daly Street Building that was not originally planned in phase one in order to meet the increased demand for this service and ultimately increase profits margins.

Once operational, the division will oversee the trimming, drying, curing, grading and packaging of cannabis, and support TransCanna’s strategy of vertical integration of the California cannabis market through distribution centers serving Northern California from the Daly Street building, and Southern California from the Company’s recently announced Lemoore facility.

“Once we received our final State License for the Daly Building, our already existing demand increased significantly. To meet this demand and seize the opportunity we saw to really drive our bottom line margin through processing, we sped up the timeline to add processing at this level,” said Bob Blink, TransCanna CEO. “We have the team and the space to execute this. Being agile enough to adapt to a changing market and identify opportunities for growth within it speaks to our collective mindset. When we run the numbers, we can see upon execution this service adding an additional 10% to our forecasted revenue targets,” adds Blink.

“This will facilitate the larger strategy of the Daly facility becoming a central distribution point for Lyfted Branded products and a wholesale processing center,” said Alan Applonie, company General Manager. “Converging marketing and buying interests into a single Northern California location gives state-wide buyers a broader range of products to purchase,” he adds.

The Processor License is an additional license type not included in the original statute specifically added for processors. As this is a new business segment whilst being built out, the Company has submitted an application for a Processor License and anticipates approximately a 90-day timeline to receive it.

The Daly building’s phase one deployment plan will also accommodate perpetual storage of at least 20,000 lbs. of cannabis flower in a climate-controlled atmosphere that will serve business-to-business cannabis market demand throughout California.

About TransCanna Holdings Inc.

TransCanna Holdings Inc. is a California based, Canadian listed, Company building cannabis-focused brands for the California lifestyle, through its wholly-owned California subsidiaries.

For further information, please visit the Company’s website at www.transcanna.com or email the Company at [email protected].

On behalf of the Board of Directors
Bob Blink, CEO
604-349-3011

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws or forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs regarding future events of management of the Company. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or “occur”. This information and these statements referred to herein as “forward-looking statements”, are not historical facts, are made as of the date of this news release and include without limitation estimates and forecasts and statements as to management’s expectations for growth and the commencement of operations of the Company’s Daly facility.

The forward-looking information in this press release is based upon certain assumptions that management considers reasonable in the circumstances, including that operations will commence at the Company’s Daly facility in Modesto, California, as and when expected.

These forward-looking statements involve numerous known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially from any future results, events or developments expressed or implied by such forward-looking statements. Risks and uncertainties associated with the forward-looking information in this news release include, among others, dependence on obtaining and maintaining regulatory approvals, including state, local or other licenses and any inability to obtain all necessary governmental approvals licenses and permits to complete upgrades to its Daly facility in a timely manner; engaging in activities which currently are illegal under U.S. federal law and the uncertainty of existing protection from U.S. federal or other prosecution; regulatory or political change such as changes in applicable laws and regulations, including U.S. state-law legalization, particularly in California, due to inconsistent public opinion, perception of the medical-use and adult-use marijuana industry, bureaucratic delays or inefficiencies or any other reasons; any other factors or developments which may hinder market growth;; reliance on management; and the effect of capital market conditions and other factors (including those related to the COVID-19 pandemic) on capital availability; competition, including from more established or better financed competitors; and the need to secure and maintain corporate alliances and partnerships, including with customers and suppliers.

Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look, except in accordance with applicable securities laws.

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN

TransCanna $TCAN.ca and Award-Winning Product Producers, the Summit Boys, to Co-Brand #Cannabis Concentrates $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 7:11 AM on Tuesday, July 21st, 2020
tcan-square
  • Announced a Memorandum of Understanding with award-winning and leading legacy cannabis brand, the Summit Boys, to co-brand a series of high-quality cannabis concentrates
  • Summit Boys are a well-known legacy recreational cannabis product producers (operating since 2016 under prop 215 and with a cult-like following on Instagram of over 66,000 followers).
  • Demand for Cannabis Concentrates are the Fastest Growing of all Related Product Categories

Vancouver, British Columbia–(July 21, 2020) – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) is pleased to announce a Memorandum of Understanding with award-winning and leading legacy cannabis brand, the Summit Boys, to co-brand a series of high-quality cannabis concentrates.

The Summit Boys are a well-known legacy recreational cannabis product producers (operating since 2016 under prop 215 and with a cult-like following on Instagram of over 66,000 followers). In this agreement, Lyfted Farms (a TransCanna subsidiary), will supply high-quality cannabis flower to the Summit Boys for processing into a line of popular cannabis concentrates branded as ‘Caviar.’

In 2019, the Summit Boys earned 14 awards in the Bay Area Cannabis Cup in several categories, including for Best Product and Hybrid Concentrate for this same Caviar product. The line of ‘White Caviar’ branded products are what The Summit Boys are best known for.

Cannabis concentrates have a greater proportion of cannabinoids and terpenes when compared to natural cannabis flowers, and can increase the potency of cannabis flower. Demand for these concentrates are also the fastest-growing of any cannabis product in the California market (the largest Cannabis market globally).

“This co-branding of the already famous Caviar product now powered by Lyfted’s flower is great news for cannabis consumers,” says Bob Blink, TransCanna CEO. “For us, it’s another example of our strategy to align with high-quality producers and already successful players in the industry-this time with the added value of the Summit Boys’ grassroots following. But for the more sophisticated California cannabis market, this partnership will mean an even higher quality product for consumers.”

“As a dedicated brand to California Cannabis market, we wanted to find like-minded partners. Since meeting the Lyfted team, they have earned our respect, and we definitely look forward to working together. There are many things that excite us, but being able to co-brand and scale now that the Daly Facility is licensed is a huge opportunity, ” stated Mike Larson, Summit Boys CEO.

News of this agreement follows an announcement by TransCanna that the Company was awarded its final operating license for the 196,000 square foot Daly Facility by the California Bureau of Cannabis Control July 10, 2020.

About TransCanna Holdings Inc.

TransCanna Holdings Inc. is a California based, Canadian listed company building Cannabis-focused brands for the California lifestyle, through its wholly-owned California subsidiaries.

For further information, please visit the Company’s website at www.transcanna.com or email the Company at [email protected].

On behalf of the Board of Directors,

Bob Blink, CEO
604-349-3011

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws or forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs regarding future events of management of the Company. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or “occur”. This information and these statements, referred to herein as “forward-looking statements”, are not historical facts, are made as of the date of this news release and include without limitation estimates and forecasts and statements as to management’s expectations for growth and the commencement of operations of the Company’s Daly facility.

The forward-looking information in this press release is based upon certain assumptions that management considers reasonable in the circumstances, including that operations will commence at the Company’s Daly facility in Modesto, California, as and when expected.

These forward-looking statements involve numerous known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially from any future results, events or developments expressed or implied by such forward-looking statements. Risks and uncertainties associated with the forward-looking information in this news release include, among others, dependence on obtaining and maintaining regulatory approvals, including state, local or other licenses and any inability to obtain all necessary governmental approvals licenses and permits to complete upgrades to its Daly facility in a timely manner; engaging in activities which currently are illegal under U.S. federal law and the uncertainty of existing protection from U.S. federal or other prosecution; regulatory or political change such as changes in applicable laws and regulations, including U.S. state-law legalization, particularly in California, due to inconsistent public opinion, perception of the medical-use and adult-use marijuana industry, bureaucratic delays or inefficiencies or any other reasons; any other factors or developments which may hinder market growth;; reliance on management; and the effect of capital market conditions and other factors (including those related to the COVID-19 pandemic) on capital availability; competition, including from more established or better financed competitors; and the need to secure and maintain corporate alliances and partnerships, including with customers and suppliers.

Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look, except in accordance with applicable securities laws.

Datametrex $DM.ca Awarded $208,800 Milestone 3 Completion Payment from Canada’s Defense Innovation Program

Posted by AGORACOM-JC at 1:01 PM on Monday, July 20th, 2020
  • Announced that it has successfully been awarded the third milestone of a multi phase R&D program through Canada’a Department of National Defence Innovation for Defence Excellence and Security (“IDEaS”) program
  • Company will be receiving approximately $208,800.00 CAD for Component 1b Milestone 3, to further develop Nexalogy SMART, Social Media Automated Reporting Technologies, while also expanding its fake news and narrative detection technologies

TORONTO, July 20, 2020 — Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G) is pleased to announce that it has successfully been awarded the third milestone of a multi phase R&D program through Canada’a Department of National Defence Innovation for Defence Excellence and Security (“IDEaS”) program.

The Company will be receiving approximately $208,800.00 CAD for Component 1b Milestone 3, to further develop Nexalogy SMART, Social Media Automated Reporting Technologies, while also expanding its fake news and narrative detection technologies.

IDEaS was announced in Canada’s new defence policy, Strong, Secure, Engaged, and commits to $1.6 billion of investment in innovations for defence and security over the next 20 years. IDEaS supports the development of solutions from their conceptual stage, through prototype testing and capability development. The program includes several elements that promote collaboration between innovators, provides developmental resources and provides opportunities to interact with DND’s science and military members. Through which all innovators are on an even playing field to solve specific defence and security challenges.

For more info about the IDEaS program please visit Department of National Defence at:  Innovation for Defence Excellence and Security (IDEaS)

“Milestone 3 completion greenlights the final phase of development for Nexalogy SMART and reflects important progress for helping the Government of Canada maintain a technological advantage in the realm of cyber social media security. We are happy to have the go ahead to continue the contract,” says Marshall Gunter, CEO of the Company.

For more information on this project or to learn how Datametrex can assist your organization in social media discovery, Fake News Filters and BOT detection please go to: www.nexalogy.com.

About Datametrex
Datametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational Health and Safety goals with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain.

Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:
Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Forward-Looking Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Else Nutrition $BABY.ca Receives Key USDA Organic Certification Ahead of Toddler Nutrition Product Launch in U.S. $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 7:20 AM on Monday, July 20th, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png
  • Key certification comes on the heels of Else-Plant Based Complete Nutrition for Toddlers going live on elsenutrition.com
  • The received USDA certification affirms that Else’s Toddler Nutrition product is fully sourced and processed according to federal organic guidelines

VANCOUVER, BC, July 20, 2020 – ELSE NUTRITION HOLDINGS INC. (TSXV: BABY) (OTCQB: BABYF) (FSE: 0YL) (“Else” or the “Company”), is pleased to announce that its novel, plant-based complete nutrition product for toddlers has received the key USDA Organic certification.

Following successful production, consultations and reviews, the toddler nutrition product is now fully certified as USDA Organic, Clean Label, Soy-Free, and Plant-Based.

The received USDA certification affirms that Else’s Toddler Nutrition product is fully sourced and processed according to federal organic guidelines (addressing among other factors, soil quality, pest and additives control), and adheres to independent and rigorous testing to ensure their certification meets a standard which enables transparency with respect to food and consumer product labelling and to preserve public health and safety for U.S. consumers.

“Attaining this key organic certification demonstrates Else’s commitment towards creating and providing safe, organic, clean label, plant-based, nutrition products – that are good for people, animals and the planet,” said Ms. Hamutal Yitzhak, Co-Founder and CEO of Else Nutrition.

Earlier this week, the Else e-store opened for pre-orders of the full-sized Else Nutrition Plant-Based Complete Nutrition for Toddlers.

About Else Nutrition Holdings Inc.

Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan. The holding company, Else Nutrition Holdings Inc, is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QB board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board  members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies,  and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children’s Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium

For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among othersForward-looking statements made in this press release assume, among others, the timing of the Company’s toddler nutrition product launch and the availability of the Company’s product online. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements.  Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

SOURCE Else Nutrition Holdings Inc.

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/July2020/20/c0840.html

Ms. Hamutal Yitzhak, CEO, Co-Founder & Director, ELSE Nutrition Holdings Inc., E: [email protected], P: +972(0)3-6445095; Mr. Sokhie Puar, Director, ELSE Nutrition Holdings Inc., E: [email protected], P: 604-603-7787Copyright CNW Group 2020

St-Georges Eco-Mining Corp. $SX $SX.ca $SXOOF Provides Lithium Processing Technology Update

Posted by AGORACOM-JC at 3:21 PM on Sunday, July 19th, 2020
https://thedeepdive.ca/wp-content/uploads/2017/12/SX-Logo.png
  • provide additional information regarding the contracted pilot plant facilities of Carrefour innovation sur les materiaux de la MRC des Sources or “CIMMS” initially disclosed in a press release on July 10, 2020
  • The Company is also providing an update on its research and development process that is now fully reactivated following a slower development period in the last quarter

Montreal, July 19, 2020 –  St-Georges Eco-Mining Corp. (CSE: SX) (OTC: SXOOF) (FSE: 85G1) is pleased to provide additional information regarding the contracted pilot plant facilities of Carrefour innovation sur les materiaux de la MRC des Sources or “CIMMS” initially disclosed in a press release on July 10, 2020. The Company is also providing an update on its research and development process that is now fully reactivated following a slower development period in the last quarter.

The pilot plant operations

The pilot plant being contracted is a “state of the art” newly-built facility owned and operated by CIMMS.

The agreement has an 18-month duration and can be extended. It marks the beginning of a new phase of testing in the development of the Company’s lithium processing technology.

CIMMS-contracted infrastructures and resources allow St-Georges Metallurgy to scale up instantly without the lag time usually experienced when research teams integrate new members and train on new equipment. CIMMS also contributes immediately to the Company’s bank of resources and expertise by making available experienced and highly respected lithium metallurgy researchers. The CIMMS-led team consists of:

Yu-Mei Han, Ph.D. Metallurgy, who is the technical director and was the process engineer during the start up of the Quebec lithium mine. She is very experienced in lithium pilot plant design and conception.

Denys Pinard, Chemist with nearly 40 years’ experience in hydrometallurgy. Denys was the 4th person hired by Quebec Lithium, where he participated in the start up of their commercial plant. His expertise revolves around lithium extraction processes, spodumene decrepitation, sulfidation, lixiviation, purification, and carbonation.

Jonathan Viens, Operation supervisor of the CIMMS, Jonathan has experience in characterization and optimization of spodumene acidulation processes. He has worked on the realization of different projects, specifically on optimizing lithium recovery.

Sylvain Couture, Eng. Director of CIMMS, Sylvain accumulates decades of experience in industrial equipment conception. Over the years, he contributed to various R&D initiatives focusing on industrial reject alternative usage and was involved in the start up of various industrial plants.

Enrico Di Cesare, St-Georges Metallurgy’s President, commented: “(…)With the extent of the partners and the laboratories we now have integrated with our research initiatives, we have the flexibility and scalability to fulfill all our research needs (…) the infrastructure and experience that is available and the elimination of team integration and equipment learning curves should reduce the lag time between design and conception and real-life industrial testing significantly. (…) The current approach allows development and innovation in parallel or allows multiple technical teams to work in conjunction to achieve innovation or solutions as required. (…) The elimination of fixed costs, building and commissioning, and the level of control we now have on our development and testing costs allow us to take chances on concepts that would have been put aside before. We will continue to focus on Key Performance Indicators but have some flexibility to try outside the box thinking and more freedom to innovate (…)”

For pictures and description of the CIMMS facilities, please scroll down to the end of this press release

Lithium Processing Technology Advancements

Shareholders and stakeholders alike should remember that the Company was able to concentrate mechanically the lithium found in the clay in the material obtained from Nevada Lithium projects. Air classification resulted in the elimination of 55% of the gangue material with no lithium loss resulting in an increase of approximately 2.2 times the lithium content in the resulting material (See Press Release “Independent Review of Phase One Lithium in Clay R&D Completed”, July 24, 2019).

Additional concentration with Nitric and Citric acid allowed for the elimination of up to 96% of the material without loss of lithium. The resulting 4% having 99.9% of the lithium still present in the solution and being equivalent to a 25-fold increase of lithium concentration in the resulting solution.


Click Image To View Full Size

Fig. 1 St-Georges’ Hydrometallurgical Lithium Extraction Process Phases

Larger scale tests now take in account the moisture content of the material, often up to 17% moisture, that the clay sediment carries and which results in almost the same percentage of acid loss that cannot be recycled in the process and also, currently, of some lithium loss up to the same 17% when the leach solution is filtered.

A conceptual scenario using 44 tonnes of feeding material from a blend of lithium-in-clay type projects would result in 24 tonnes being discarded and 20 tonnes being sent to an acid bath of 180 tonnes of a proprietary mix of acid dominated by nitric acid.

In the tests conducted during Phase I and previously disclosed, the Company metallurgists were able to leach within less than an hour, over 99.9% of the lithium into solution, at atmospheric pressure and ambient temperature.

However, the lithium needs to be recuperated, and the Phase I report initially underlined a significant challenge for the process at the time. Fine materials like clays can retain much of the acid and lithium in filter cake losses. That can represent retention of humidity that is higher than other concentrates, up to 17% compared to a maximum of up to 8% in traditional lithium concentrates obtained from spodumene hosted in hard rock material. The Company’s R&D efforts are now focused on further concentration and the reduction of acid losses in the residues.

This phenomenon seems to be universal to all lithium-in-clay projects across the industry and is not a specific situation. It impacts the recuperation grade and cannot be overlooked. Optimizing the purification steps and minimizing chemical losses will continue to be the priority along with minimizing energy requirements. The intent is also to be able to show value-added by-products such as fertilizer and start working with the industry to optimize chemistry to meet clients’ needs and improve value.

This led to an interesting discovery by the metallurgical team. A new approach was introduced in the conception of the Phase II processing technology applied to this type of material. The Company is now ready to conduct scaling tests with a proprietary adaptation of resin balls that will allow the recuperation of the lithium in the leach solution without filtration. The Company believes that this will significantly reduce the loss due to the moisture content. Tests need to be conducted on a large scale to test the potential recuperation improvements as well as the loss of acid that would remain in the acid leach containers and be recycled to process more material. It is important to note that the lithium loss due to moisture in the filtration press ends up in the mining residue without creating important challenges. However, the acid rejected constitutes a more important issue as it needs to be neutralized, increasing infrastructure, neutralization material, and workforce costs that, even if it is not estimated yet, are guaranteed to be significant. The ability to scale the solution recently discovered is then paramount and constitutes an important and positive development.


Click Image To View Full Size


Click Image To View Full Size


Click Image To View Full Size


Click Image To View Full Size

ON BEHALF OF THE BOARD OF DIRECTORS

“Vilhjalmur T. Vilhjalmsson”

VILHJALMUR THOR VILHJALMSSON


President & CEO

About Carrefour d’innovation sur les materiaux de la MRC des Sources (CIMMS)

CIMMS is a publicly funded research and development corporation located in Asbestos, Quebec. It is supported by numerous local and regional organizations, along with the provincial and federal governments. CIMMS develops and carries out technological innovation projects specifically related to the industrial, mining/metallurgy and innovative materials sectors.

About St-Georges Metallurgy Corp.

Created to manage all metallurgical research and development, joint ventures and partnerships, and hold all mineral processing technology intellectual property and patents. The Corporation is a wholly-owned subsidiary of St-Georges Eco-Mining Corp.

About St-Georges Eco-Mining Corp.

St-Georges is developing new technologies to solve some of the most common environmental problems in the mining industry. The Company controls all the active mineral tenures in Iceland. It also explores for nickel on the Julie Nickel Project & the Manicouagan Palladium Project on Quebec’s North Shore and for lithium and rare metals in Northern Quebec and in the Abitibi region. Headquartered in Montreal, St-Georges’ stock is listed on the CSE under the symbol SX, on the US OTC under the Symbol SXOOF and on the Frankfurt Stock Exchange under the symbol 85G1

The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.

Datametrex $DM.ca Appoints New Chief Financial Officer

Posted by AGORACOM-JC at 1:46 PM on Friday, July 17th, 2020
  • Announced the appointment of Andrea Yuan, BA, CPA, CGA as new Chief Financial Officer
  • Prior to joining Datametrex, Ms. Yuan was Chief Financial Officer for several public companies listed on the TSX Venture Exchange. She and has been involved in several private placements, prospectus filings, flow-through financings, and corporate audits. Andrea is fluent in both English and Mandarin (oral and written).

TORONTO, July 17, 2020 – Datametrex AI Limited (“Datametrex” or the “Company”) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce the appointment of Andrea Yuan, BA, CPA, CGA as new Chief Financial Officer (“CFO”).

This new addition to the Company’s executive leadership team brings with her nearly 26 years of financial experience in accounting and financial control with a combination of private and public companies in a variety of industries including cannabis, resource, and financial services. Andrea Yuan will work to ensure Datametrex’s financial health through strategic planning and management of the company’s finances.

Prior to joining Datametrex, Ms. Yuan was Chief Financial Officer for several public companies listed on the TSX Venture Exchange. She and has been involved in several private placements, prospectus filings, flow-through financings, and corporate audits. Andrea is fluent in both English and Mandarin (oral and written).

“I am thrilled to join Datametrex and this impressive leadership team with a history of growing great companies,” said Andrea Yuan. “Datametrex’s newly announced Health Security with selling Covid-19 test kit is well positioned for success, and I am happy to be a part of this journey.”

Ms. Yuan is a Certified General Accountant in British Columbia and a Certified Public Accountant in New Hampshire. She obtained her Bachelor of Economics from Shanghai University of Finance and Economics in 1994. Ms. Yuan started her career as an internal auditor and then as team head of the internal audit department at the Bank of China’s Shanghai Pudong branch in China from 1994 through to 1999. After arriving in Canada in spring of 1999, Andrea worked as an accountant at a small accounting firm while she worked towards her CGA designation.

Andrea moved to Davidson and Company LLP, Chartered Accountants, in 2004 where she worked in the firm’s audit group. From November 2006 until 2009, Andrea was employed as an audit manager at Davidson. From 2009 until October 2011, Ms. Yuan was employed as an audit principal at Davidson. In addition to overseeing a variety of Canadian public company audit files, she was also responsible for conducting the audits of various foreign public companies including Chinese and Korean companies.

“On behalf of the executive team and our Board of Directors, I would like to thank Steve Kang for his dedication and hard work during his tenure as CFO. I wish Steve nothing but success in his future endeavours. The appointment of Ms. Yuan as the Company’s new CFO represents a great addition to our leadership team, and I look forward to working with Andrea as we move the Company forward,” said Marshall Gunter, CEO of the Company.

Steve Kang, the current CFO of the Company, has resigned from his position and will stay on for the next several weeks to support Datametrex during the transition of the financial leadership.

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy. Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

TransCanna $TCAN.ca Commences “Phase 1” Construction and Roll-Out of Commercial Activities at Flagship Daly Facility $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 7:01 AM on Thursday, July 16th, 2020
tcan-square
  • Begun preparations for the commercial launch of distribution activities at its flagship 196,000 square foot Daly Avenue Facility in Modesto California
  • Goal of Phase 1 is to focus on expansion and ramp-up of the companies’ distribution activities
  • Revised design of Phase 1 of the Daly Distribution build-out increases capacity by 16,000 square feet, allowing the Company to expand this core business unit to service escalating demand from customers

Vancouver, British Columbia–(July 16, 2020) – TransCanna Holdings Inc. (CSE: TCAN) (XETR: TH8) (“TransCanna” or the “Company”) is pleased to announce that with the recent state-wide final license approval, today its wholly-owned subsidiary, Lyfted Farms, Inc. (“Lyfted”), has begun preparations for the commercial launch of distribution activities at its flagship 196,000 square foot Daly Avenue Facility in Modesto California.

The goal of Phase 1 is to focus on expansion and ramp-up of the companies’ distribution activities. The revised design of Phase 1 of the Daly Distribution build-out increases capacity by 16,000 square feet, allowing the Company to expand this core business unit to service escalating demand from customers.

“After many months of planning and preparation, our team is thrilled to begin operations inside of Daly,” said CEO Bob Blink. “We look forward to rewarding our investors’ patience with this initial phase and present the true potential we believe The Daly Building has to offer. As early as Q4 2020, we expect to see an incremental increase in revenue from Distribution activities in the vicinity of $6,000,000 CDN per quarter. When combined with existing revenues, our target run-rate by our fiscal year-end should exceed previous projections and be in the neighborhood of $36,000,000 CDN.”

Lyfted Farms has accepted a contract with Bay Alarm Company to install a state of the art, integrated security system in preparation for commercial activity at the Daly facility. Pre-site preparations are underway, and system completion is expected by August 15, 2020.

Additionally, the facility’s triple-redundancy heating, ventilation, and air conditioning “HVAC,” sub-forty-degree Fahrenheit freezer, and distribution area systems have been activated for pre-cooling and calibration within the areas of operation. Employee technician training has started on the Company’s high speed automated packaging systems, combining WeighPack Swifty Baggers and Combiscale 14-head rotary scales to provide high-efficiency and precision filling, which reduce labor and material costs to industry-leading levels.

Packaging and support materials began arriving this week into the Daly distribution center with completion of the Phase 1 Distribution build-out expected by September 15, 2020.

About TransCanna Holdings Inc.

TransCanna Holdings Inc. is a California based, Canadian listed company building Cannabis-focused brands for the California lifestyle, through its wholly-owned California subsidiaries.

For further information, please visit the Company’s website at www.transcanna.com or email the Company at [email protected].

On behalf of the Board,

Bob Blink, CEO
604-349-3011

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws or forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs regarding future events of management of the Company. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or “occur”. This information and these statements, referred to herein as “forward‐looking statements”, are not historical facts, are made as of the date of this news release and include without limitation estimates and forecasts and statements as to management’s expectations for growth and the commencement of operations of the Company’s Daly facility.

The forward-looking information in this press release is based upon certain assumptions that management considers reasonable in the circumstances, including that operations will commence at the Company’s Daly facility in Modesto, California as and when expected.

These forward‐looking statements involve numerous known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially from any future results, events or developments expressed or implied by such forward-looking statements. Risks and uncertainties associated with the forward looking information in this news release include, among others, dependence on obtaining and maintaining regulatory approvals, including state, local or other licenses and any inability to obtain all necessary governmental approvals licenses and permits to complete upgrades to its Daly facility in a timely manner; engaging in activities which currently are illegal under U.S. federal law and the uncertainty of existing protection from U.S. federal or other prosecution; regulatory or political change such as changes in applicable laws and regulations, including U.S. state-law legalization, particularly in California, due to inconsistent public opinion, perception of the medical-use and adult-use marijuana industry, bureaucratic delays or inefficiencies or any other reasons; any other factors or developments which may hinder market growth;; reliance on management; and the effect of capital market conditions and other factors (including those related to the COVID-19 pandemic) on capital availability; competition, including from more established or better financed competitors; and the need to secure and maintain corporate alliances and partnerships, including with customers and suppliers.

Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look, except in accordance with applicable securities laws.

Hollister Biosciences $HOLL.ca Provides Update on Q2 2020, Generated Record Quarterly Revenue of CDN$ 11.5 Million and Announces Distribution License Renewal $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 8:05 PM on Tuesday, July 14th, 2020
  • Generated record quarterly revenue of CDN$ 11.5 million,
  • CDN$ 1.375 million in EBITDA
  • Bureau of Cannabis Control officially renewed its cannabis distribution license for the next year through August 2021

VANCOUVER, BC, July 14, 2020 – Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) (FRANKFURT: HOB) (the “Company“, “Hollister Cannabis Co.” or “Hollister“) a diversified cannabis branding company with products in over 230 dispensaries throughout California, and over 80 dispensaries throughout Arizona,  is pleased to provide an update on its Q2, 2020 performance as well as announce that the Bureau of Cannabis Control (“BCC“) officially renewed its cannabis distribution license for the next year through August 2021.

Q2 2020 Update

For the period beginning April 1st, 2020 and ending June 30th, 2020, Hollister reports that it generated record quarterly revenue of CDN$ 11.5 million and CDN$ 1.375 million in EBITDA from its product line of pre-rolls, concentrates, distillates, solvent-free bubble hash, pre-packaged flower, tinctures and vape products.  The Company cautions that revenue and EBITDA figures have not yet been audited and are based on reports prepared by management.

“We are very pleased with our revenue growth year to date.  Sales of cannabis related products have proven to be resilient throughout the COVID-19 pandemic.  We hope to continue to deliver strong results as the year progresses” stated Carl Saling, CEO.

About the BCC

The Bureau of Cannabis Control is the lead agency in regulating commercial cannabis licenses for medical and adult-use cannabis in California. The BCC is responsible for licensing retailers, distributors, testing laboratories, microbusinesses, and temporary cannabis events. A distributor (Type 11) licensee is responsible for transporting cannabis goods between licensees, arranging for testing of cannabis goods, and conducting the quality assurance review of cannabis goods to ensure compliance with all packaging and labeling requirements. A licensed distributor may only distribute cannabis goods, cannabis accessories, and licensees’ branded merchandise or promotional materials.

“Our distribution license is a critical component to our California operation, and we are honored to have had our license renewed by the BCC” stated Carl Saling, CEO.

About Hollister Biosciences Inc.

Hollister Biosciences Inc. is a multi-state cannabis company with a vision to be the sought-after premium brand portfolio of innovative, high-quality cannabis & hemp products. Hollister uses a high margin model, controlling the whole process from manufacture to sales to distribution or seed to shelf. Products from Hollister Biosciences Inc. include HashBone, the brand’s premier artisanal hash-infused pre-roll, along with concentrates (shatter, budder, crumble), distillates, solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures. Hollister Cannabis Co. additionally offers white-labeling manufacturing of cannabis products.  Our wholly-owned California subsidiary Hollister Cannabis Co is the 1st state and locally licensed cannabis company in the city of Hollister, CA birthplace of the “American Biker”.

Website: www.hollistercannabisco.com

The CSE, nor its regulation services provider, does not accept responsibility for the adequacy or accuracy of this release.

Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements”. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com

Augmented reality #AR heads-up displays for cars are finally a real thing – SPONSOR: Imagine AR $IP.ca $IPNFF $SEV.ca $VST.ca $YDX.ca $NTAR.ca

Posted by AGORACOM-JC at 9:51 AM on Tuesday, July 14th, 2020

SPONSOR: Imagine AR Inc. (IP:CSE) (IPNFF:OTCQB) is an Augmented Reality platform that allows businesses to easily launch AR campaigns. Clients Include: NBA Sacramento Kings, Mall of America, AT&T Shape and The Basketball Hall of Fame. The company recently announced partnership with Engaged Nation, an award winning leader in digital engagement marketing for casinos in addition to a collaboration with Music Superstar Flo Rida Learn More.

http://www.smallcapepicenter.com/imagine%20ar%20squre.jpg

Augmented reality heads-up displays for cars are finally a real thing

By: Jonathan M. Gitlin

When Audi briefed Ars on its newest electric car, the part that most piqued our interest was the news that the Q4 e-tron Sportback will feature an augmented reality heads-up display. As we explained in that article, Audi didn’t feel like elaborating much on the new technology. Perhaps it wishes it had, as it’s going to be beaten to the punch by its deadly rival Mercedes-Benz. When the 2021 S-Class debuts in September, the brand’s flagship sedan will offer an AR HUD, among other tech upgrades.

The automaker has even been forthcoming with some technical info on this latest driver assist. It uses a digital mirror device from Texas Instruments—perhaps no surprise given that TI has been developing automotive AR tech for a while now. The DMD has a resolution of 1.3 megapixels (or megamirrors, to be strictly accurate) and projects onto a 10˚ horizontal, 5˚ vertical aperture HUD, with the image appearing 33 feet (10m) away. (Mercedes-Benz says it’s the equivalent of a 77-inch monitor.)

Unfortunately, Mercedes-Benz hasn’t shared any still images of the AR HUD in action, and there were only a few seconds of video in the b-roll that the company provided. But the automaker did helpfully tweet out a longer video this morning, which we’ve embedded below, as it really is the best way to see how the system works. (If the embedded tweet isn’t showing up for you, you can view it here.)

Ready for the next level of displays? The augmented reality head-up display (AR-HUD) of the new #SClass provides loads of #augmentedreality content for #drivingassistance systems and navigation information. #MercedesBenz #MBUX pic.twitter.com/LwGqGJvRjB

— Daimler AG (@Daimler) July 10, 2020

As you can see, it fuses various sensor inputs from the vehicle like the forward-looking radar as well as optical sensors to alert or inform the driver. That information could be the distance to a car you’re following, or markers delineating the edge of the road in low-light situations, or navigation help via directional arrows that work a bit like the optimal racing line overlay in games like Forza.

I’ll admit it: I’m excited that this tech is finally making its way into production and I’m eager to try it out, although some in the automotive UX world are not entirely convinced that a limited field-of-view HUD is the right way to implement this idea versus a full AR windshield.

That tech was considered unworkable a few years ago, and early practical demos of AR driver assists used goggles instead. But by CES in 2019 there were already static demos from companies like Saint-Gobain Sekurit and the aforementioned TI. A successful implementation will require restraint on the part of the UX designers, with AR elements being used sparingly to avoid information overload that could actually be even more distracting to drivers. But given that the problem of distracted driving is partly a problem of where a driver is looking, AR has the potential to save lives.

Source: https://arstechnica-com.cdn.ampproject.org/c/s/arstechnica.com/cars/2020/07/augmented-reality-heads-up-displays-for-cars-are-finally-a-real-thing/?amp=1